Frontier Wealth Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-14,812
Closed -$741K – 398
2020
Q4
$741K Buy
+14,812
New +$628K 0.06% 186

Other funds holding RPRX

Frontier Wealth Management's RPRX Position: Q1 2021 in Review

Frontier Wealth Management sold out of Royalty Pharma (RPRX) in Q1 2021, closing a stake of 14,812 shares — an estimated $741K sold.

Frontier Wealth Management first reported a position in RPRX in Q4 2020 and held it in 1 quarter. The position peaked at $741K in Q4 2020. 214 funds tracked by Wall St. Rank hold RPRX as of Q1 2021.

  • Frontier Wealth Management reported no remaining Royalty Pharma position as of Q1 2021 after selling out during the quarter.
  • Frontier Wealth Management sold 14,812 Royalty Pharma shares in Q1 2021, an estimated $741K.
  • Frontier Wealth Management first reported a position in Royalty Pharma in Q4 2020 and held it in 1 quarter.
  • Frontier Wealth Management's Royalty Pharma position peaked at $741K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2021.

Based on Frontier Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.